#United States #financial results #dividend increase #Cigna Group #Bloomfield

The Cigna Group Reports Strong 2024 Results and Optimistic 2025 Outlook

On January 30, 2025, The Cigna Group, a leading global health services company, unveiled its impressive financial results for the year 2024, highlighting significant growth driven primarily by the success of its Evernorth Health Services segment. Total revenues surged by 27% to reach an astounding $247.1 billion. This remarkable performance underlines Cigna's expansive market reach and commitment to delivering value to its shareholders, clients, and customers.

Financial Highlights

In the fourth quarter alone, Cigna's net income was reported at $1.4 billion, translating to $5.13 per share compared to $1.0 billion, or $3.49 per share during the same period in 2023. For the full year 2024, shareholders enjoyed a net income of $3.4 billion, equating to $12.12 per share, impacted significantly by a non-cash after-tax investment loss attributed to VillageMD equity securities.

Adjusted income from operations for 2024 was approximately $7.7 billion, or $27.33 per share, demonstrating a 4% year-on-year growth. Despite encountering challenges from increased medical costs in its stop-loss insurance product, the company has proactively addressed these issues while pursuing its long-term growth strategy.

A Vision for 2025

Looking ahead, Cigna has established an optimistic outlook for 2025, projecting adjusted income from operations of at least $7.9 billion, or $29.50 per share. Such projections are bolstered by expected client acquisitions, operational efficiencies, and additional share repurchase programs totaling $10.3 billion as a result of an 8% dividend increase, bringing the new quarterly dividend to $1.51 per share.

David M. Cordani, the chairman and CEO, stated, “While higher medical costs in our stop-loss product impacted fourth quarter earnings, we are taking corrective actions to address these near-term pressures and we are simultaneously taking steps to further advance our long-term growth strategy.”

Key Performance Drivers

The results from Evernorth Health Services reflect the strength of Cigna's diversified health services model. In 2024, this segment saw a remarkable increase in adjusted revenues, resulting from client wins and strong specialty volume growth. Specifically, both Pharmacy Benefit Services and Specialty and Care Services segments showed robust growth, reporting adjusted revenues of $111.8 billion and $90.3 billion, respectively, for the year.

In addition to revenue growth, total customer relationships at Cigna reached 182.2 million, an 11% increase from 2023, driven largely by new pharmacy customer acquisitions which increased by 20% during the year.

Conclusion

The Cigna Group's 2024 financial results exemplify its commitment to delivering value while navigating challenges in the healthcare landscape. With strong revenue growth, a clear strategy for maintaining operational efficiency, and a dedication to enhancing customer relationships, Cigna is well-positioned to continue its trajectory of success into 2025 and beyond.